[1]
2024. PHARMACOLOGICAL AND CLINICAL PROFILE OF REBAMIPIDE: NEW THERAPEUTIC TARGETS. International journal of medical sciences. 4, 12 (Dec. 2024), 444–446. DOI:https://doi.org/10.55640/.